Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Cell Responsiveness to GIP With and Without Sulfonylurea in T2D
NCT00321321Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- May 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of glipizide in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Gentofte Hospital. Primary endpoint: Insulin Secretion. Started May 2006; status: completed.
02
Drugs
glipizide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00321321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321321.